• KSAN
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Original Article

Comparison of Blood Glucose Levels from the Fingertips of Both Patients with and without Diabetes Who are Receiving Dextrose Fluid Therapy

Korean Journal of Adult Nursing 2016;28(2):127-135.
Published online: April 30, 2016

1Department of Nursing, Samsung Medical Center, Seoul

2Department of Nursing, Korean Christian University, Seoul, Korea

Corresponding author: Lee, Chang Kwan Department of Nursing, Korea Christian University, 47 24-gil, Kkachisan-ro, Gangseo-gu, Seoul 07661, Korea Tel: +82-2-2600-2546, Fax: +82-2-2600-2524, E-mail: jejuslee@hanmail.net
• Received: October 29, 2015   • Accepted: April 22, 2016

Copyright © 2016 Korean Society of Adult Nursing

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 26 Views
  • 0 Download
next
  • Purpose
    The aim of this study was to identify the effect of dextrose intravenous fluid (IVF) on the blood glucose levels taken from both fingertips of patients with diabetes mellitus (DM) and those without DM.
  • Methods
    From October 2012 to February 2013, 21 DM and 25 non-DM patients were recruited. Blood glucose levels taken from the both fingertips of patients at 7AM while IVF was not infusing and at 11AM, 5PM, and 9PM while IVF was infusing.
  • Results
    The differences between the mean values of blood glucose from the fingertips at four different times was not statistically significant in DM patients as well as non-DM patients. Also intra-class correlation for blood glucose levels from the fingertips with and without IVF infusion in both groups was shown over about 0.95 at each time (p<.001).
  • Conclusion
    Blood glucose levels measured in the same fingertips of both arms were the same regardless of dextrose IVF infusion. The results indicated that IVF with dextrose may not have any significant effect on the fingertip results of blood glucose level. This study may suggest that patients' both arms and any fingertips can be used for blood glucose monitoring even when the patients are on dextrose IVF infusion.
Table 1.
General and Disease-related Characteristics of the Participants (N=46)
Characteristics Categories DM (n=21) Non-DM (n=25)
n (%) or M±SD n (%) or M±SD
Gender Male 12 (57.1) 11 (44.0)
Female 9 (42.9) 14 (56.0)
Age (year)   65.5±10.4 53.7±13.3
20~39 0 (0.0) 4 (16.0)
40~59 4 (19.0) 10 (40.0)
60~79 17 (81.0) 11 (44.0)
Duration after DM diagnosis (year)   7.0±6.6  
DM medication Yes 20 (95.2) 0 (0.0)
No 1 (4.8) 25 (100.0)
Diagnoses Hepatobiliary tumor 8 (38.1) 10 (40.0)
Pancreatic cancer 6 (28.6) 14 (56.0)
Stomach cancer 6 (28.6) 1 (4.0)
Gallstones 1 (4.7) 0 (0.0)
RI injection Yes 11 (52.4) 0 (0.0)
No 10 (47.6) 25 (100.0)
Dose (unit) 7.0±3.4  
Fluid volume (mL) 9AM~9PM 941.5±138.1 981.3±173.0

DM=diabetes mellitus; Non-DM=non-diabetes mellitus; RI=regular insulin;

Including glibenclamide, glimepiride, or meformin.

Table 2.
Blood Glucose on the Fingertip before IV Infusion (N=46)
Time Measure site for blood glucose (mg/dL) DM (n=21) Non-DM (n=25)
M±SD Z p  M±SD t p
7AM with IV 138.95±44.81 -.13 .896 107.20±15.82 1.98 .059
without IV 143.95±45.16     102.88±15.68    

DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

Table 3.
Differences of the Blood Glucose in the Both Fingertips during IV Infusion (N=46)
Time Measure site for blood glucose (mg/dL) M±SD Non-DM (n=25)
DM (n=21) Z p M±SD t p
11AM with IV 202.55±63.70 -1.08 .291 123.16±30.25 -1.24 .226
without IV 204.68±65.65     126.24±30.66    
5PM with IV 133.45±32.03 .20 .841 101.92±8.19 -1.19 .246
without IV 134.18±36.67     103.76±11.18    
9PM with IV 139.86±29.25 -.43 .673 101.44±13.48 -.87 .393
without IV 140.64±37.16     102.56±12.22    
Mean with IV 158.41±54.31 -.10 .919 108.84±21.94 1.98 .115
without IV 159.98±58.33     110.85±22.68    

DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

Table 4.
Intra-class Correlation of the Blood Glucose on the Fingertip between with/without IV Infusion (N=46)
Time DM (n=21) Non-DM (n=25)
ICC Lower 95% CI Upper 95% CI p ICC Lower 95% CI Upper 95% CI p
7AM .96 .90 .98 <.001 .86 .69 .94 <.001
11AM .98 .96 .99 <.001 .96 .90 .98 <.001
5AM .96 .90 .98 <.001 .82 .58 .92 <.001
9AM .95 .88 .98 <.001 .93 .85 .97 <.001
Mean .98 .97 .99 <.001 .95 .92 .96 <.001

DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous; ICC=intra-class correlation; CI=confidence interval.

Table 5.
Changes in the Blood Glucose Levels according to Time (N=46)
Variables Group 7AM 11AM 5AM 9AM F p Scheffé F (G) F (T) F (G*T)
M±SD M±SD M±SD M±SD (p) (p) (p)
DM with IV 138.95±44.81a 202.55±63.70b 133.45±32.03a 139.86±29.25a 20.47 <.001 b>a 0.05 25.58 0.04
  without IV 143.95±45.16a 204.68±65.65b 134.18±36.67a 140.64±37.16a 19.68 <.001 b>a (.832) (<.001) (.991)
Non-DM with IV 107.20±15.82a 123.16±30.25b 101.92±8.19a 101.44±13.48a 6.89 <.001 b>a 0.01 12.32 0.85
  without IV 102.88±15.68a 126.24±30.66b 103.76±11.18a 102.56±12.22a 9.36 <.001 b>a (.914) (<.001) (.473)

DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

  • 1.Jamieson EH, Whyte LA, McCal JMIntravenous therapy. Clinical Nursing Practices. 5th ed.. Edinburgh: Churchill Living-stone; 2007. p. p169-86. Cited by Younger G, Khan M. Setting up and priming an intravenous infusion, Nursing Standard 2008; 22 (40): 40-4..http://dx.doi.org/10.7748/ns2008.06.22.40.40.c6571.
  • 2.Suh IS, Song SO, Park DP. Effect of starvation and perioperative fluid therapy on the blood glucose concentrations during anesthesia in children. Yeungnam University Medicine. 1984;8(1):89-93.
  • 3.Park JG, Cheun JK, Kim AR. The effect of IV solution during cesarean section on umbilical glucose, electrolyte and insulin. Journal of Korean Society of Anesthesiologists. 1995;28(5):661-8.
  • 4.Watson KR, O'Kell RT, Joyce JT. Data regarding blood drawing sites in patients receiving intravenous fluids. American Journal of Clinical Pathology. 1983;79(1):119-21.
  • 5.Chang CW, Chung JK. Changes in blood sugar, insulin, osmor-ality and electrolytes with intraoperative infusion of various situation. Korean Journal of Anesthesiology. 1987;20(5):656-67.
  • 6.Huh IY, Baek CH, Lee JD, Shin JW, Gwak MJ. Effects of fluid therapy on serum glucose level in pediatric outpatients. Korean Journal of Anesthesiology. 2006 Feb;50(2):158-61.
  • 7.Yang JWThe relationship between blood glucose level and fluids administered during perioperative period in fasted children. [master's thesis]. Gwangju: Chosun University; 2010.
  • 8.Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798-807. http://dx.doi.org/10.1016/S0140-6736(09)60553-5.
  • 9.Kim GS, Choi GY, Hyeun GS, Yoon YJ, Kim SY, Kim YS, et alMedical surgical nursing. 7th ed.. Reston: Soomoonsa; 2014. p. 979.1460-61, 1473..
  • 10.Korean Diabetes Association. Committee of Clinical Practice Guideline [Internet]. Seoul: Korean Diabetes Association; 2015. [cited 2016 April 19]. Available from:.http://www.diabetes.or.kr/pro/publish/guide.php.
  • 11.Isbell TS, Lyon ME. Glucose meters Where are we now? Where are we heading? Medical Laboratory Observer. 2012 Jun;44(6):16-8.
  • 12.Korean Agency for Technology and Stands. In vitro diagnostics test systems- Requirements for blood glucose monitoring systems for self testing in managing diabetes mellitus 2010;KSP ISO 15197..
  • 13.Park HJ, Park CS, Park CM, Ryu KH, Chang HW, Cho EJ, et al. Assessment of blood glucose values measured by blood gas analyzer or portable glucometer. Korean Journal of Anesthesiology. 2006;50(5):506-10.
  • 14.Diamond SA, Matok I. Pharmacists'anticipated pain compared to experienced pain associated with insulin pen injection and fingertip lancing. Canadian Journal of Diabetes. 2011;35(3):282-6. http://dx.doi.org/10.1016/S1499-2671(11)53012-6.
  • 15.Park MS, Park KS, Kim KA, Cha YJ, Jun MH, Kim TI, et al. Pain and blood volume with different sampling sites and puncture depths in vacuum assisted auto lancing technique for blood glucose test. Journal of Korean Academic Society of Nursing Education. 2006;12(2):265-71.
  • 16.Lock JP, Szuts EZ, Malomo KJ, Anagnostopoulos A. Whole-blood glucose testing at alternate sites: Glucose values and hematocrit of capillary blood drawn from fingertip and forearm. Diabetes Care. 2002 Feb;25(2):337-41.
  • 17.Bina DM, Anderson RL, Johnson ML, Bergenstal RM, Kendall DM. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care. 2003 Apr;26(4):981-5.
  • 18.Ong YY, Boyken SF, Barnett RN. You can draw blood from the “IV arm” below the intravenous needle if you put a tourniquet in between. American Journal of Clinical Pathology. 1979;72(1):101-2.
  • 19.Lee JS, Kim JY, Lee HS, Moon HG, Lee JR, Kim SA. Actual performance of self-monitoring of blood glucose by diabetic patients. Journal of Korean Clinical Nursing Research. 2002;18(1):99-115.
  • 20.Cowett RM, D'Amico L. Capillary (Heelstick) versus venous blood sampling for the determination of glucose concentration in the neonate. Biology of the Neonate: Fetal and Neonatal Research. 1992;62:32-6.
  • 21.Choi JY. A Comparison on the degree of pain according to methods of blood sugar test between DM patients and healthy group. Journal of Korean Academy of Nursing. 2003;33(7):928-35.
  • 22.Shin DW, Kim JS, Han SB, Lee JH, Kim AJ, Kim JH, et al. Evaluation of the fingerstick blood glucometer for patients with poor peripheral perfusion. Journal of the Korean Society of Emergency Medicine. 2002;13(1):73-7.
  • 23.Park KS, Song YY, Park MS, Kim KO, Choi SS, Kim KA, et al. Measurement accuracy of blood glucose test on the forearm. Journal of the Korea Academia-Industrial Cooperation Society. 2009;10(9):2451-9.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Comparison of Blood Glucose Levels from the Fingertips of Both Patients with and without Diabetes Who are Receiving Dextrose Fluid Therapy
      Korean J Adult Nurs. 2016;28(2):127-135.   Published online April 30, 2016
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Comparison of Blood Glucose Levels from the Fingertips of Both Patients with and without Diabetes Who are Receiving Dextrose Fluid Therapy
      Korean J Adult Nurs. 2016;28(2):127-135.   Published online April 30, 2016
      Close
      Comparison of Blood Glucose Levels from the Fingertips of Both Patients with and without Diabetes Who are Receiving Dextrose Fluid Therapy
      Comparison of Blood Glucose Levels from the Fingertips of Both Patients with and without Diabetes Who are Receiving Dextrose Fluid Therapy

      General and Disease-related Characteristics of the Participants (N=46)

      Characteristics Categories DM (n=21) Non-DM (n=25)
      n (%) or M±SD n (%) or M±SD
      Gender Male 12 (57.1) 11 (44.0)
      Female 9 (42.9) 14 (56.0)
      Age (year)   65.5±10.4 53.7±13.3
      20~39 0 (0.0) 4 (16.0)
      40~59 4 (19.0) 10 (40.0)
      60~79 17 (81.0) 11 (44.0)
      Duration after DM diagnosis (year)   7.0±6.6  
      DM medication Yes 20 (95.2) 0 (0.0)
      No 1 (4.8) 25 (100.0)
      Diagnoses Hepatobiliary tumor 8 (38.1) 10 (40.0)
      Pancreatic cancer 6 (28.6) 14 (56.0)
      Stomach cancer 6 (28.6) 1 (4.0)
      Gallstones 1 (4.7) 0 (0.0)
      RI injection Yes 11 (52.4) 0 (0.0)
      No 10 (47.6) 25 (100.0)
      Dose (unit) 7.0±3.4  
      Fluid volume (mL) 9AM~9PM 941.5±138.1 981.3±173.0

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; RI=regular insulin;

      Including glibenclamide, glimepiride, or meformin.

      Blood Glucose on the Fingertip before IV Infusion (N=46)

      Time Measure site for blood glucose (mg/dL) DM (n=21) Non-DM (n=25)
      M±SD Z p  M±SD t p
      7AM with IV 138.95±44.81 -.13 .896 107.20±15.82 1.98 .059
      without IV 143.95±45.16     102.88±15.68    

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      Differences of the Blood Glucose in the Both Fingertips during IV Infusion (N=46)

      Time Measure site for blood glucose (mg/dL) M±SD Non-DM (n=25)
      DM (n=21) Z p M±SD t p
      11AM with IV 202.55±63.70 -1.08 .291 123.16±30.25 -1.24 .226
      without IV 204.68±65.65     126.24±30.66    
      5PM with IV 133.45±32.03 .20 .841 101.92±8.19 -1.19 .246
      without IV 134.18±36.67     103.76±11.18    
      9PM with IV 139.86±29.25 -.43 .673 101.44±13.48 -.87 .393
      without IV 140.64±37.16     102.56±12.22    
      Mean with IV 158.41±54.31 -.10 .919 108.84±21.94 1.98 .115
      without IV 159.98±58.33     110.85±22.68    

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      Intra-class Correlation of the Blood Glucose on the Fingertip between with/without IV Infusion (N=46)

      Time DM (n=21) Non-DM (n=25)
      ICC Lower 95% CI Upper 95% CI p ICC Lower 95% CI Upper 95% CI p
      7AM .96 .90 .98 <.001 .86 .69 .94 <.001
      11AM .98 .96 .99 <.001 .96 .90 .98 <.001
      5AM .96 .90 .98 <.001 .82 .58 .92 <.001
      9AM .95 .88 .98 <.001 .93 .85 .97 <.001
      Mean .98 .97 .99 <.001 .95 .92 .96 <.001

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous; ICC=intra-class correlation; CI=confidence interval.

      Changes in the Blood Glucose Levels according to Time (N=46)

      Variables Group 7AM 11AM 5AM 9AM F p Scheffé F (G) F (T) F (G*T)
      M±SD M±SD M±SD M±SD (p) (p) (p)
      DM with IV 138.95±44.81a 202.55±63.70b 133.45±32.03a 139.86±29.25a 20.47 <.001 b>a 0.05 25.58 0.04
        without IV 143.95±45.16a 204.68±65.65b 134.18±36.67a 140.64±37.16a 19.68 <.001 b>a (.832) (<.001) (.991)
      Non-DM with IV 107.20±15.82a 123.16±30.25b 101.92±8.19a 101.44±13.48a 6.89 <.001 b>a 0.01 12.32 0.85
        without IV 102.88±15.68a 126.24±30.66b 103.76±11.18a 102.56±12.22a 9.36 <.001 b>a (.914) (<.001) (.473)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      Table 1. General and Disease-related Characteristics of the Participants (N=46)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; RI=regular insulin;

      Including glibenclamide, glimepiride, or meformin.

      Table 2. Blood Glucose on the Fingertip before IV Infusion (N=46)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      Table 3. Differences of the Blood Glucose in the Both Fingertips during IV Infusion (N=46)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      Table 4. Intra-class Correlation of the Blood Glucose on the Fingertip between with/without IV Infusion (N=46)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous; ICC=intra-class correlation; CI=confidence interval.

      Table 5. Changes in the Blood Glucose Levels according to Time (N=46)

      DM=diabetes mellitus; Non-DM=non-diabetes mellitus; IV=intravenous.

      TOP